ACM
INSM icon

Aster Capital Management’s Insmed INSM Stock Holding History

Aster Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
11,814
+11,762
+22,619% +$1.42M 0.27% 112
2026
Q1 		$3.97K Buy
+52
New +$8K ﹤0.01% 699
2025
Q4 		– Sell
-348
Closed -$50.1K – 1255
2025
Q3 		$50.1K Sell
348
-5,732
-94% -$702K 0.03% 501
2025
Q2 		$612K Sell
6,080
-3,191
-34% -$244K 0.14% 177
2025
Q1 		$756K Buy
9,271
+9,251
+46,255% +$708K 0.14% 213
2024
Q4 		$1.38K Buy
+20
New +$1.44K ﹤0.01% 995

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Aster Capital Management's INSM Position: Q2 2026 in Review

Aster Capital Management increased its Insmed (INSM) stake by 22,619% in Q2 2026, buying an estimated $1.42M and bringing the position to 11,814 shares worth $1.26M. The position accounts for 0.27% of the portfolio, ranked #112.

Aster Capital Management first reported a position in INSM in Q4 2024 and has held it in 6 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Aster Capital Management held 11,814 shares of Insmed worth $1.26M as of Q2 2026.
  • Aster Capital Management bought 11,762 Insmed shares in Q2 2026, an estimated $1.42M.
  • Insmed made up 0.27% of Aster Capital Management's portfolio in Q2 2026, its #112 holding.
  • Aster Capital Management first reported a position in Insmed in Q4 2024 and has held it in 6 quarters since.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.